Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Dunning

Showing results (101-110 of 357) with videos related to

Pageof 36
Sort By:
Ebiomedicine|August 13, 2016
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate CancerSarah L Kerns, Leila Dorling, Laura Fachal, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
JAMA|November 4, 2004
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomesJohn P A Ioannidis, Stuart H Ralston, Simon T Bennett, et al.
Familial Cancer|June 14, 2021
First international workshop of the ATM and cancer risk group (4-5 December 2019)Fabienne Lesueur, Douglas F Easton, Anne-Laure Renault, et al.
Nature Genetics|April 2, 2014
POT1 loss-of-function variants predispose to familial melanomaCarla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, et al.
International Journal of Molecular Epidemiology and Genetics|September 15, 2011
Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery diseaseSally L Ricketts, Katrijn L Rensing, Jeff M Holly, et al.
Journal of Medical Genetics|April 3, 2021
Characterisation of protein-truncating and missense variants in <i>PALB2</i> in 15 768 women from Malaysia and SingaporePei Sze Ng, Rick Acm Boonen, Eldarina Wijaya, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy ToxicityGillian C Barnett, Sarah L Kerns, Leila Dorling, et al.
Journal of the National Cancer Institute|October 16, 2024
Polygenic risk scores stratify breast cancer risk among women with benign breast diseaseMark E Sherman, Stacey J Winham, Robert A Vierkant, et al.
Pageof 36

Showing results (101-110 of 357) with videos related to

Sort By:
Pageof 36
Ebiomedicine|August 13, 2016
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate CancerSarah L Kerns, Leila Dorling, Laura Fachal, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
JAMA|November 4, 2004
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomesJohn P A Ioannidis, Stuart H Ralston, Simon T Bennett, et al.
Familial Cancer|June 14, 2021
First international workshop of the ATM and cancer risk group (4-5 December 2019)Fabienne Lesueur, Douglas F Easton, Anne-Laure Renault, et al.
Nature Genetics|April 2, 2014
POT1 loss-of-function variants predispose to familial melanomaCarla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, et al.
International Journal of Molecular Epidemiology and Genetics|September 15, 2011
Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery diseaseSally L Ricketts, Katrijn L Rensing, Jeff M Holly, et al.
Journal of Medical Genetics|April 3, 2021
Characterisation of protein-truncating and missense variants in <i>PALB2</i> in 15 768 women from Malaysia and SingaporePei Sze Ng, Rick Acm Boonen, Eldarina Wijaya, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy ToxicityGillian C Barnett, Sarah L Kerns, Leila Dorling, et al.
Journal of the National Cancer Institute|October 16, 2024
Polygenic risk scores stratify breast cancer risk among women with benign breast diseaseMark E Sherman, Stacey J Winham, Robert A Vierkant, et al.
Pageof 36